Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

US VAC permissions granted for Episurf Medical

Episurf Medical

Episurf Medical (Nasdaq: EPIS B) today announces several recent permissions granted from health systems' Value Analysis Committees (VACs) within the United States. While typical sales cycles begin with interest from an orthopaedic surgeon, review and access to begin doing surgeries must almost always first be granted by individual VACs. Recently, among others, the company has received approval to initiate surgeries within facilities at:

  • Vail Health System (affiliated with the Steadman Clinic) - Vail, Colorado
  • The Hospital for Special Surgery - New York, New York
  • Dartmouth Health System - Lebanon, New Hampshire

"VAC approvals are a pivotal step in our sales cycles. While we often think of our customers as orthopaedic surgeons and while this is true to some degree, in reality hospitals, surgery centers, and healthcare systems are the entities actually purchasing our products. We're grateful some of the country's leading and most prestigious health systems have recently granted us access, and we are looking forward to beginning productive commercial relationships with each of them," said Patrick Jamnik, President of Episurf Medical, Inc.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.